Literature DB >> 17368445

Motor neuron regeneration accuracy: balancing trophic influences between pathways and end-organs.

Timothy Uschold1, Grant A Robinson, Roger D Madison.   

Abstract

The key to recovery of function following peripheral nerve lesions is guiding axons back to their original target end-organs. The parent femoral nerve splits into two comparable terminal pathways: one to the muscle and the other to the skin. Normally, motor neurons only innervate the pathway to the muscle, but after the parent nerve is repaired regenerating motor neurons are often misrouted to the skin. When the muscle and skin pathways remain connected to their respective targets after the parent nerve is repaired, reinnervation favors the muscle pathway. If contact with the muscle is instead prevented, reinnervation favors the pathway to the skin. Here we examine whether shortening the skin pathway can alter motor reinnervation accuracy when the muscle pathway remains connected to the muscle. We demonstrate that reducing the influence of the skin pathway results in a more rapid and extensive reinnervation of the muscle pathway. These findings suggest that the relative balance of trophic influences from the pathways and their end-organs is an important determinant of motor neuron regeneration accuracy, and that the muscle pathway by itself is not the primary regulator for regeneration accuracy of motor neurons.

Mesh:

Year:  2007        PMID: 17368445     DOI: 10.1016/j.expneurol.2007.02.005

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  14 in total

1.  Accuracy of regenerating motor neurons: influence of diffusion in denervated nerve.

Authors:  R D Madison; G A Robinson
Journal:  Neuroscience       Date:  2014-05-15       Impact factor: 3.590

2.  C3 peptide promotes axonal regeneration and functional motor recovery after peripheral nerve injury.

Authors:  Stefanie C Huelsenbeck; Astrid Rohrbeck; Annelie Handreck; Gesa Hellmich; Eghlima Kiaei; Irene Roettinger; Claudia Grothe; Ingo Just; Kirsten Haastert-Talini
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

3.  Polysialic acid expression is not necessary for motor neuron target selectivity.

Authors:  Grant A Robinson; Roger D Madison
Journal:  Muscle Nerve       Date:  2012-11-21       Impact factor: 3.217

4.  Coiled polymeric growth factor gradients for multi-luminal neural chemotaxis.

Authors:  Nesreen Zoghoul Alsmadi; Lokesh S Patil; Elijah M Hor; Parisa Lofti; Joselito M Razal; Cheng-Jen Chuong; Gordon G Wallace; Mario I Romero-Ortega
Journal:  Brain Res       Date:  2015-03-21       Impact factor: 3.252

Review 5.  Pleiotrophin and peripheral nerve injury.

Authors:  Li Jin; Chen Jianghai; Liu Juan; Kang Hao
Journal:  Neurosurg Rev       Date:  2009-05-08       Impact factor: 3.042

6.  Sensory axon targeting is increased by NGF gene therapy within the lesioned adult femoral nerve.

Authors:  Xinhua Hu; Jie Cai; Jun Yang; George M Smith
Journal:  Exp Neurol       Date:  2009-09-04       Impact factor: 5.330

7.  Peptide mimetic of the S100A4 protein modulates peripheral nerve regeneration and attenuates the progression of neuropathy in myelin protein P0 null mice.

Authors:  Mihai Moldovan; Volodymyr Pinchenko; Oksana Dmytriyeva; Stanislava Pankratova; Kåre Fugleholm; Jorg Klingelhofer; Elisabeth Bock; Vladimir Berezin; Christian Krarup; Darya Kiryushko
Journal:  Mol Med       Date:  2013-04-30       Impact factor: 6.354

8.  Schwann cell influence on motor neuron regeneration accuracy.

Authors:  R D Madison; M V Sofroniew; G A Robinson
Journal:  Neuroscience       Date:  2009-06-06       Impact factor: 3.590

9.  Adult motor axons preferentially reinnervate predegenerated muscle nerve.

Authors:  M Abdullah; A O'Daly; A Vyas; C Rohde; T M Brushart
Journal:  Exp Neurol       Date:  2013-08-08       Impact factor: 5.330

10.  Motor neuron target selectivity and survival after prolonged axotomy.

Authors:  Grant A Robinson; Roger D Madison
Journal:  Restor Neurol Neurosci       Date:  2013       Impact factor: 2.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.